Soleus Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-14,794	Closed	-$3.42M	–	74
2020 Q2	$3.42M	Sell	14,794 -6,666	-31%	-$1.54M	1.95%	15
2020 Q1	$2.5M	Buy	21,460 +3,133	+17%	+$365K	2.91%	13
2019 Q4	$3.5M	Buy	+18,327	New	+$3.5M	3.38%	8